日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

更正：肿瘤 Akkermansia muciniphila 可预测 PD-L1 低表达的非小细胞肺癌患者对免疫检查点抑制剂的临床反应

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1827736
Shimizu, Takashi; Ohkuma, Ryotaro; Homma, Mayumi; Nakayama, Shingo; Sasaki, Yosuke; Muto, Satoshi; Ieguchi, Katsuaki; Watanabe, Makoto; Taguchi, Akashi; Takayanagi, Daisuke; Wada, Youichiro; Horiike, Atsushi; Kubota, Yutaro; Ariizumi, Hirotsugu; Shimokawa, Masahiro; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Mura, Emiko; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Suzuki, Hiroyuki; Yamochi, Toshiko
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Mouse model of anti-RANKL discontinuation reveals reduced bone mass and quality through disruption of bone remodeling

小鼠抗RANKL药物停用模型显示，骨重塑紊乱导致骨量和骨质量下降。

期刊:Bone Research
影响因子:15
doi:10.1038/s41413-025-00433-0
Ishikawa, Koji; Tani, Soji; Sakai, Nobuhiro; Kudo, Yoshifumi; Horiuchi, Hideyo; Kimura-Suda, Hiromi; Takami, Masamichi; Tsuji, Mayumi; Inagaki, Katsunori; Kiuchi, Yuji; Negishi-Koga, Takako
RAN
Mouse
发表日期：2025
文献求助 收藏

Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

肿瘤阿克曼菌（Akkermansia muciniphila）可预测PD-L1低表达的非小细胞肺癌患者对免疫检查点抑制剂的临床反应

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1528594
Shimizu, Takashi; Ohkuma, Ryotaro; Homma, Mayumi; Nakayama, Shingo; Sasaki, Yosuke; Muto, Satoshi; Ieguchi, Katsuaki; Watanabe, Makoto; Taguchi, Akashi; Takayanagi, Daisuke; Wada, Youichiro; Horiike, Atsushi; Kubota, Yutaro; Ariizumi, Hirotsugu; Shimokawa, Masahiro; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Mura, Emiko; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Suzuki, Hiroyuki; Yamochi, Toshiko
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors

韦荣氏球菌和链球菌与肠道菌群老化有关，并影响免疫检查点抑制剂的疗效。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1528521
Hirasawa, Yuya; Isobe, Junya; Hosonuma, Masahiro; Tsurui, Toshiaki; Baba, Yuta; Funayama, Eiji; Tajima, Kohei; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Shida, Midori; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Uchida, Naoki; Wada, Satoshi; Kobayashi, Shinichi; Kiuchi, Yuji; Kuramasu, Atsuo; Yoshimura, Kiyoshi; Tsunoda, Takuya
微生物学
肠道菌群
衰老
免疫/内分泌
发表日期：2025
文献求助 收藏

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity

肌苷可调控PD-1阻断反应，并与PD-1/CTLA-4双重免疫疗法产生协同作用，从而增强抗肿瘤免疫力。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04111-2
Narikawa, Yoichiro; Kuramasu, Atsuo; Hosonuma, Masahiro; Murayama, Masakazu; Funayama, Eiji; Sasaki, Akiko; Baba, Yuta; Toyoda, Hitoshi; Isobe, Junya; Tajima, Kohei; Nakashima, Rie; Sasaki, Aya; Maruyama, Yuki; Yamazaki, Yoshitaka; Shida, Midori; Tsurui, Toshiaki; Hirasawa, Yuya; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Horiike, Atsushi; Kobayashi, Shinichi; Tsunoda, Takuya; Kobayashi, Sei; Kobayashi, Hitome; Oguchi, Tatsunori; Shimane, Toshikazu; Kiuchi, Yuji; Yoshimura, Kiyoshi
肿瘤
肿瘤免疫
信号转导
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study

血浆WFDC2（HE4）作为接受抗PD-1治疗的癌症患者临床结局的预测性生物标志物：一项初步研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142384
Watanabe, Makoto; Ieguchi, Katsuaki; Shimizu, Takashi; Ohkuma, Ryotaro; Suzuki, Risako; Mura, Emiko; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ikeda, Go; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Yoshimura, Kiyoshi; Horiike, Atsushi; Tsunoda, Takuya; Tsuji, Mayumi; Kobayashi, Shinichi; Oguchi, Tatsunori; Kiuchi, Yuji; Wada, Satoshi
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study

嗜酸性粒细胞与免疫检查点抑制剂在多种癌症中的疗效：一项回顾性研究

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13123029
Suzuki, Risako; Ohkuma, Ryotaro; Watanabe, Makoto; Mura, Emiko; Tsurui, Toshiaki; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ikeda, Go; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Yoshimura, Kiyoshi; Kobayashi, Shinichi; Tsunoda, Takuya; Horiike, Atsushi; Tsuji, Mayumi; Kiuchi, Yuji; Oguchi, Tatsunori; Wada, Satoshi
Checkpoint
肿瘤
肿瘤免疫
粒细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study

利用腰大肌指数评估患者免疫检查点抑制剂治疗的免疫功能：一项回顾性队列研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1499650
Tsurui, Toshiaki; Hamada, Kazuyuki; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Tsunoda, Takuya
免疫/内分泌
发表日期：2025
文献求助 收藏

Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers.

血浆中 WAP 四二硫键核心结构域 2 水平升高可作为多种癌症的潜在预后生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1614102
Watanabe Makoto, Ieguchi Katsuaki, Onishi Nobuyuki, Shimizu Takashi, Ohkuma Ryotaro, Suzuki Risako, Mura Emiko, Iriguchi Nana, Ishiguro Tomoyuki, Hirasawa Yuya, Ikeda Go, Shimokawa Masahiro, Ariizumi Hirotsugu, Horiike Atsushi, Yoshimura Kiyoshi, Tsunoda Takuya, Tsuji Mayumi, Kobayashi Shinichi, Kiuchi Yuji, Wada Satoshi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8(+) T cells as a predictor of clinical benefit

Ki-67在抗程序性细胞死亡蛋白-1抗体结合的CD8(+) T细胞中的表达可作为临床获益的预测指标

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02060-x
Tsurui, Toshiaki; Hosonuma, Masahiro; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Funayama, Eiji; Tajima, Kohei; Toyoda, Hitoshi; Isobe, Junya; Yamazaki, Yoshitaka; Baba, Yuta; Shida, Midori; Udaka, Yuko; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Kuramasu, Atsuo; Tsuji, Mayumi; Kiuchi, Yuji; Tsunoda, Takuya; Yoshimura, Kiyoshi
T细胞
T细胞
CD8
免疫/内分泌
细胞生物学
Ki-67
发表日期：2025
文献求助 收藏